Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

A look at technology combinations
October 2018
SHARING OPTIONS:

TEL AVIV, Israel—Cellect Biotechnology Ltd. and the denovoMATRIX group of the Technische Universität Dresden announced a collaboration and material transfer agreement this summer. Per the agreement, the denovoMATRIX team will assess the synergy between Cellect’s ApoGraft technology and the denovoMATRIX technology to evaluate collaborative development of products for regenerative medicine, with a scientist from denovoMATRIX to conduct experiments at Cellect’s Israeli R&D site. A combination of their technologies is something the organizations feel could significantly enhance the stem cell selection and expansion process. Should the evaluation stage be deemed successful—which falls to Cellect’s discretion—the partners have both agreed to negotiate a potential mutual development agreement to develop a stem cell-related product.
 

Back



PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2018 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.